CareGLP Storefront Compliance Check Process

Before launching any CareGLP storefront, our team performs a thorough compliance check to protect storefront owners from potential legal claims, particularly those involving trademark infringement, false advertising, and unfair competition. This review ensures that the content, branding, and advertising practices on the storefront align with relevant legal standards and regulations, minimizing the risk of exposure to claims like those seen in lawsuits involving pharmaceutical companies such as Eli Lilly.

Duration of Compliance Check

A typical compliance check spans one week, though this may extend based on the storefront's complexity, particularly regarding the display of branded medications or references to FDA-approved drugs. During this time, storefront owners cannot make any changes to their storefront, ensuring that the review process is consistent and thorough.

Key Focus Areas

• Trademark Infringement: We scrutinize the use of any trademarks (such as MOUNJARO® and ZEPBOUND®) to prevent the unauthorized use of protected names, logos, or product representations that could mislead consumers into believing they are purchasing FDA-approved medications or affiliated products.

• False Advertising and Deceptive Trade Practices: Our team verifies that all marketing claims are clear and compliant with FDA regulations. For example, compounded medications should not be marketed as FDA-approved or as achieving the same outcomes as FDA-approved drugs unless supported by appropriate evidence. CareGLP ensures that descriptions avoid misleading claims like labeling compounded products as “Generic MOUNJARO®” or falsely implying FDA approval.

• Cybersquatting and Domain Management: We review domain names and online branding to ensure there are no violations of cybersquatting laws. For instance, using domains that incorporate pharmaceutical trademarks (such as “mounjarodoctor.com”) can result in legal challenges. Our review helps avoid such issues by guiding storefront owners in selecting appropriate domain names.

• Compounded Drug Compliance: If the storefront offers compounded medications, we ensure all content clearly differentiates between FDA-approved medications and compounded alternatives, warning customers of the inherent risks involved in using unapproved compounded drugs. This helps prevent claims based on false representations, such as advertising compounded tirzepatide as equivalent to branded drugs like MOUNJARO® or ZEPBOUND®.

Disclaimer

While CareGLP’s compliance check is designed to reduce the likelihood of legal exposure and ensure adherence to best practices, it does not guarantee that pharmaceutical companies or other parties will not take legal action. The compliance check is intended to help storefront owners avoid common mistakes, particularly those related to intellectual property, advertising, and product representation, but it cannot account for all potential legal risks.

Through this comprehensive review, CareGLP strives to protect storefront owners from legal claims, allowing them to launch their businesses with confidence while minimizing the chances of litigation. However, ongoing vigilance and compliance with evolving regulations are crucial to maintaining a legally sound storefront.